Both in Pharmaceuticals
Q32 Bio vs Fulcrum Therapeutics
Over the past year QTTB returned +278.5% and FULC returned −55.0%; their daily moves had a correlation of -0.03.
QTTB +278.5% FULC −55.0%Growth of $1, one year, split-adjusted
| Metric | QTTB | FULC |
|---|---|---|
| Price | $8.97 | $3.77 |
| Market cap | $267.0M | $288.0M |
| Today | +2.40% | +0.80% |
| 1 month | +10.6% | +2.2% |
| 6 months | +64.0% | −47.0% |
| Year to date | +170.2% | −66.7% |
| 1 year | +249.0% | −58.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 7.9× | — |
| Price / sales | 5.0× | — |
| Net cash | $106.3M | $318.8M |
| Dividend yield | — | — |
| Volatility (60d) | 63.1% | 15.0% |
| Short % of float | 32.6% | 10.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).